CLINICAL_TRIALS
trial_result
· 2023-06-27
Clinical Trial Update: MT10109L in the Treatment of Glabellar Lines [Phase 3]
Summary
Phase 3 trial for MT10109L in treating glabellar lines has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Medy-Tox | Conditions: Glabellar Lines | Phase 3 | Status: COMPLETED | Results posted: 2023-06-27